M&S Decisions attended the ASCO 2020 Virtual Scientific Program, USA

Researchers from M&S Decisions presented their work entitled “Comparative quantitative safety profiles of PD-1 and PD-L1 checkpoint inhibitor monotherapies: A Bayesian model-based meta-analysis” (Abstract # e15167). Comparison of safety profiles of PD-1 and PD-L1 checkpoint inhibitor monotherapies was shown using a Bayesian model-based meta-analysis.